Document is current

Article History

Accepted: 21 August 2024

First Online: 30 November 2024

Compliance with Ethical Standards

:

: None.

: TG discloses Travel fees from AstraZeneca, Gilead, and Pfizer. Consulting/Advisor role for AstraZeneca and Cancerologie-pratique. Research funding: Amgen. Personal Grant from Philippe Foundation.ER: Travel, Accommodations, Expenses: Pfizer, Roche, Mundipharma; Grants: Gilead (institutional); Honoraria: Eli Lilly.JDD: travel and accommodation support to attend educational meetings from Novartis, MSD and Pierre Fabre. Received honoraria for provision of educational material for Gilead.JRM: travel and accommodation support from Gilead Sciences; honoraria from eESO, Gilead Sciences, Inc., Astra Zeneca and MSD for participation in advisory boards and educational content.AZ: personal fees and non-financial support from Novartis, Astra-Zeneca, Eli-Lilly, Pfizer, Daiichi Sankyo, MSD, Roche, Seagen, Exact Sciences, Gilead.AS: Advisor: Bristol- Myers-Squibb (BMS), Servier, Gilead, Pfizer, Eisai, Bayer, Merck Sharp and Dohme (MSD); consultancy for Arqule, Sanofi, Incyte; Speaker’s bureau: Takeda, BMS, Roche, Abb-Vie, Amgen, Celgene, Servier, Gilead, AstraZeneca, Pfizer, Arqule, Lilly, Sandoz, Eisai, Novartis, Bayer, MSD.BP: Consulting/Advisor: Puma Biotechnology, Novartis, Myriad Genetics, Pierre Fabre; Personal fees: Novartis, AstraZeneca, MSD Oncology, Pfizer; Research funding: Daiichi-Sankyo, Puma Biotechnology, Novartis, Merus, Pfizer, AstraZeneca.

: This article does not contain any studies with human or animal subjects performed by any of the authors.